Achieved positive clinical study results from the AD04-103 pharmacokinetics (PK) study supporting AD04’s pharmacologic profile and regulatory strategy. Received a positive response from the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results